1. Stocks
    2. /
  2. Pfizer (NYSE: PFE)
    3. /

Pfizer (NYSE: PFE) Share Price and News

$29.56 $0.35 (1.2%) 16 October 2026 at 12:40:49 am AEDT

Pfizer Chart and Price Data

About Pfizer

Last updated 16-10-2026, 12:40:49am AEDT
Current Price $29.56
Change $0.35 (1.2%)
Close Price $29.21
Open Price $29.57
Bid $29.55
Ask $29.56
Day Range $29.51 - $29.88
Year Range $23.62 - $29.88
Volume 3,797,780
Average Volume 35,572,910
Market Cap $166,487,360,700.00
Earnings Per Share $0.76

    • Pfizer (NYSE: PFE)
    Latest News

    A young man clasps his hand to his head with a pained expression on his face and a laptop in front of him.
    International Stock News

    3 subtle investing mistakes I won't repeat in 2025 and beyond

    | Alex Carchidi

    You can avoid the mistakes I made...

    Read more »

    A woman researcher holds a finger up in happiness as if making the 'number one' sign with a graphic of technological data and an orb emanating from her finger while fellow researchers work in the background.
    International Stock News

    2 top trends to invest $2,000 in ahead of the crowd

    | Alex Carchidi

    These two trends on the frontier of medicine could present lucrative opportunities for investment.

    Read more »

    A child covering his eyes hiding from a toy bear.
    International Stock News

    3 steps you'll regret not taking during this bear market

    | Alex Carchidi

    The last step is by far the hardest.

    Read more »

    a medical person in full protective clothing holds a tray of Covid-19 vaccinations amid a haze caused by cold and ice.
    Healthcare Shares

    ResApp share price frozen as $180m Pfizer takeover bid hangs in the balance

    | Brooke Cooper

    The value of Pfizer's takeover bid may soon come to light.

    Read more »

    Stethoscope with a piggy bank and hundred dollar notes.
    Exchange-Traded Funds (ETFs)

    A defensive ASX ETF for a recessionary environment: experts

    | Bernd Struben

    In an ageing world newly aware of the potential threats posed by pandemics, healthcare shares have received plenty of attention…

    Read more »

    Smiling health care workers in a medical setting.
    Healthcare Shares

    Imugene (ASX:IMU) share price leaps 9% on Pfizer, Merck deal

    | Bernd Struben

    Cooperation between drug developers could speed up the delivery of effective treatments.

    Read more »

    four excited doctors with their hands in the air
    Exchange-Traded Funds (ETFs)

    Expert reveals top pandemic ETF play – up 58% in 12 months

    | Bernd Struben

    COVID variants are likely to drive longer-term demand for mRNA vaccines.

    Read more »

    A businessman's hands surround a circular graphic with a United States flag and dollar signs.
    ASX Share Market News

    ASX investors were buying Alibaba, Pfizer shares last week

    | Sebastian Bowen

    Which US shares were ASX investors buying last week?

    Read more »

    A happy doctor in a white coat dancing due to his excitement over the EBOS acquisition
    Healthcare Shares

    Why the IDT (ASX:IDT) share price is rocketing 25% on Wednesday

    | Marc Sidarous

    The company claims it can make 100 million doses of mRNA vaccine within 18 months.

    Read more »

    girl receiving pfizer vaccine
    International Stock News

    Why Pfizer shot 4% higher on Tuesday

    | Eric Volkman

    New York City introduces a sweeping vaccination mandate, as authorities struggle to keep the coronavirus at bay.

    Read more »

    Bottle of tablets spilling over onto piles of US dollars
    International Stock News

    Why the Pfizer share price shot higher on Wednesday

    | Eric Volkman

    The company's powerful growth isn't only due to its coronavirus vaccine.

    Read more »

    Female patient receives Pfizer covid vaccine administered by female doctor
    Coronavirus News

    TGA approves Pfizer vaccine for kids aged 12-15 years old

    | Marc Sidarous

    The Therapeutics Goods Administration decided to approve the vaccine for kids late last night.

    Read more »

    Profile

    since

    Note